Barbara Alicja Jereczek-Fossa

European Institute of Oncology

Papers

1

Total Citations

4

H-Index

1

About

Barbara Alicja Jereczek-Fossa is a leading figure in radiation oncology and urological cancer research, with a particular focus on integrating advanced surgical and radiotherapeutic techniques. Her work spans the treatment of prostate, testicular, and other genitourinary malignancies, where she has pioneered studies on stereotactic body radiotherapy (SBRT) and the role of robotic surgery. Notably, her 2025 paper comparing open versus robot-assisted retroperitoneal lymph node dissection for testis cancer—already garnering 4 citations—exemplifies her commitment to refining oncological outcomes while minimizing surgical morbidity. Beyond this, her extensive body of work, with thousands of citations, has shaped clinical guidelines for prostate cancer radiotherapy, including hypofractionation and salvage treatments. A professor at the University of Milan and director of the Radiotherapy Division at the European Institute of Oncology, she has also been instrumental in developing multidisciplinary care models. Her research not only advances precision medicine but also empowers clinicians with evidence-based strategies for managing complex genitourinary cancers, making her a pivotal voice in modern oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Retroperitoneal lymph node dissection for testis cancer: a comparison between open and robot-assisted approach in oncological and surgical outcomes
4 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: European Institute of Oncology

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago